Sequencing and Stratification of Systemic Therapy in HCC Symposium
Participate in the symposium in two different formats: On-demand symposium from Monday, September 7th LIVE Q&A session on Saturday, September 12, 2020: 4:20 PM – 4:35 PM CEST
Lorenza Rimassa, Deputy Director Medical Oncology Unit Humanitas Cancer Center Humanitas Research Hospital – IRCCS, Milan, Italy
R.Kate Kelley, Associate Professor of Clinical Medicine in the Department of Medicine at the University of California, San Francisco (UCSF) and the UCSF Helen Diller Family Comprehensive Cancer Center (HDFCCC), USA
Join us to discuss the rapidly expanding systemic treatment landscape for advanced HCC!
In this session, we have invited leading experts to present and discuss a variety of challenges, including:
The expanding role ofsystemic therapyacross stages in HCC
How to approach sequencing the multiple systemic therapy agents and regimens now available
Systemic therapy for special populations
Evolving considerations for clinical trial endpoints
The role of biomarkers in systemic therapy for HCC
Benefit from the ILCA 2020 Virtual Conference Educational Grant
If you are a student or a trainee in the liver cancer field, you can benefit from an Educational Grant to attend the ILCA 2020 Virtual Conference and receive 1-year free ILCA membership. Interested in this opportunity? Then send us an email!